GlassScriptNext Gen Ankle - R&D
Payments companies reported to CMS as associated with Next Gen Ankle - R&D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Next Gen Ankle - R&D, per program year, as reported to CMS.
Who makes it
- Vilex LLC $29K associated with Next Gen Ankle - R&D (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Next Gen Ankle - R&D
These are the largest totals companies reported as associated with Next Gen Ankle - R&D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jesse Doty | Chattanooga, TN | Orthopaedic Surgery | $15,142.87 |
| Christopher Gross | Charleston, SC | Foot and Ankle Surgery | $5,212.98 |
| Taggart Gauvain | Pearland, TX | Foot and Ankle Surgery | $4,432.88 |
| Paul Fortin | Royal Oak, MI | Orthopaedic Surgery | $4,247.82 |
Prescribed Next Gen Ankle - R&D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.